[A cancer vaccine consisting of dendritic cells harvested from a patient with cancer and pulsed or transduced with a peptide fragment of MART-1 (melanoma antigen recognized by T-cells), an antigen expressed by melanoma cells. When the altered dendritic cells are returned to the patient, they stimulate the host immune system to mount a cytotoxic T-lymphocyte immune response against tumor cells expressing MART-1. (NCI04) ( NCI )]
UMLS (NCI) C0393062 - Amino Acid, Peptide, or Protein
- Pharmacologic Substance
- Immunologic Factor
home 
Armenian-English 
top